Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging.
Zawin M, McCarthy S, Scoutt L, Lange R, Lavy G, Vulte J, Comite F. Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging. Radiology 1990, 175: 503-6. PMID: 2109336, DOI: 10.1148/radiology.175.2.2109336.Peer-Reviewed Original ResearchConceptsGonadotropin-releasing hormone analoguePlacebo groupGnRH analoguesDrug groupsHormone analogueMR imagingMonths of therapyConservative therapyFibroid volumeSignificant changesUterine leiomyomaMagnetic resonanceTherapyMonthsSignificant decreaseWomenEndometriosisSignificant reductionVessel conspicuityGroupImagingEndometriomasPatientsLeiomyomaPelvisHigh-field MRI and US evaluation of the pelvis in women with leiomyomas
Zawin M, McCarthy S, Scoutt L, Comite F. High-field MRI and US evaluation of the pelvis in women with leiomyomas. Magnetic Resonance Imaging 1990, 8: 371-376. PMID: 2202877, DOI: 10.1016/0730-725x(90)90044-3.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingCul-de-sac fluidEndometrial stripeUterine volumeTransabdominal ultrasonographyUS evaluationCul de sacMarked enlargementUS examinationUterine leiomyomaContour abnormalitiesUltrasonographyEntire pelvisLeiomyomaResonance imagingJunctional zoneSac fluidHigh-field magnetic resonance imagingMR scansWomenUterusPelvisOvariesExaminationSubmucosal